BoobyBiome is a London-based biotechnology company focused on the science of breast milk and the microbiome. Founded in 2019 by Dr Lydia Mapstone, Dr Sioned Jones and Dr Tara O’Driscoll, its work builds on over five years of research at the UCL Great Ormond Street Institute of Child Health. The company has created the world’s largest high-resolution breast milk microbiome database and a biobank of proprietary strains that capture beneficial bacterial diversity in human milk. It has developed a patented storage device compatible with any storage bottle that preserves the natural microbiome, antioxidants and vitamins while preventing contamination. BoobyBiome is also developing a live microbiome drop composed of bacteria isolated from breast milk to support the developing microbiomes of formula-fed, C-section, or preterm infants. The company recently raised £2.5m in seed funding to commercialize the storage device, continue R&D on the live drop, expand its commercial team and scale internationally.

Total raised

$3M

Funding rounds

1

Latest round

Seed

Latest activity

Sep 2025